Kenneth Bahrt
CIK 1527197 · View on SEC EDGAR ↗
First SEC filing: May 12, 2016 · Latest: May 12, 2016
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 25, 2018 | OTLK | S | 7,700 | $0.85 | $6,545 | 47,120 Direct | -14.05% | Disposed | -99.5% (price as of 2026-08-20) |
| Dec. 22, 2017 | OTLK | S | 26,165 | $1.13 | $29,566 | 54,820 Direct | +91.31% | Acquired | -99.6% (price as of 2026-08-20) |
| May 13, 2016 | OTLK | P | 1,000 | — | — | 1,000 Direct | — | Acquired | (price as of 2026-08-20) |
| May 13, 2016 | OTLK | P | 1,000 | — | — | 1,000 Direct | — | Acquired | (price as of 2026-08-20) |
| May 13, 2016 | OTLK | P | 2,000 | — | — | 2,000 Direct | — | Acquired | (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 19, 2019 | OTLK | Stock Option (Right to Buy) | Common Stock (600,000) | $1.32 | Feb. 19, 2029 | 600,000 | Acquired |
| Oct. 22, 2018 | OTLK | Stock Option (Right to Buy) | Common Stock (450,000) | $0.90 | Oct. 22, 2028 | 450,000 | Acquired |
| May 13, 2016 | OTLK | Series B Warrants (right to buy) | Common Stock (1,000) | $8.50 | May 18, 2018 | 1,000 | Acquired |
| May 13, 2016 | OTLK | Series A Warrants (right to buy) | Common Stock (1,000) | $6.60 | Feb. 18, 2017 | 1,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| May 12, 2016 | OTLK | Restricted Stock Units [F1] | 28,985 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
OTLK
M.D.(5)Former Chief Medical Officer| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2018 | $400,000 | — | — | — | — | — | — | $429,082 |
| 2017 | $400,000 | $100,000 | $108,209 | — | — | — | $21,469 | $629,678 |
| 2016 | $310,202 | — | — | — | — | — | $22,174 | $412,416 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.